Cargando…

Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis

BACKGROUND: The anti-inflammatory effect of glycyrrhizin has been widely recognized, while the specific mechanism of glycyrrhizin in psoriasis remains poorly understood. RESULTS: In the imiquimod-induced mouse model of psoriasis (IMD), we found that glycyrrhizin can substantially improve the adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiong, Huang, Han, Ling, Zhang, Nanxue, Chen, Huyan, Yan, Kexiang, Zhang, Zhenghua, Ma, Ying, Xu, Jinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161965/ https://www.ncbi.nlm.nih.gov/pubmed/34044769 http://dx.doi.org/10.1186/s12865-021-00421-z

Ejemplares similares

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis
por: Yan, Kexiang, et al.
Publicado: (2023)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

IL-17A exacerbates psoriasis in a STAT3 overexpressing mouse model
por: Xie, Xinran, et al.
Publicado: (2023)

Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
por: Fan, Xiaojing, et al.
Publicado: (2019)

Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis
por: Zhang, Fuxin, et al.
Publicado: (2022)

B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis
por: Yang, Wenjing, et al.
Publicado: (2022)

Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
por: Bunte, Kübra, et al.
Publicado: (2019)

Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin
por: Si, Xiaoqing, et al.
Publicado: (2014)

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer
por: Quatresooz, Pascale, et al.
Publicado: (2012)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

Role of subnetworks mediated by [Formula: see text] , IL-23/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis
por: Pandey, Rakesh, et al.
Publicado: (2021)

Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
por: Bugaut, Hélène, et al.
Publicado: (2021)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid
por: Graebin, Cedric Stephan
Publicado: (2017)

The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio
por: Wang, Bing, et al.
Publicado: (2022)

Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
por: Res, Pieter C. M., et al.
Publicado: (2010)

The contribution of IL-17 to the development of autoimmunity in psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

Immunohistochemical Comparison of IL-36 and the IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis
por: Song, Hyo Sang, et al.
Publicado: (2016)

Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma
por: Tang, Qiu, et al.
Publicado: (2013)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

IL-17: Balancing Protective Immunity and Pathogenesis
por: Sun, Lu, et al.
Publicado: (2023)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
por: Zhu, Jie, et al.
Publicado: (2022)

The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics
por: Zhang, Zengjie, et al.
Publicado: (2019)

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
por: Liu, Jiang-Min, et al.
Publicado: (2021)

Trichinella pseudospiralis-secreted 53 kDa protein ameliorates imiquimod-induced psoriasis by inhibiting the IL-23/IL-17 axis in mice
por: Khueangchiangkhwang, Sukhonthip, et al.
Publicado: (2022)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
por: Tsukazaki, Hiroyuki, et al.
Publicado: (2020)

Prevalence of psoriatic arthritis in Chinese population with psoriasis: A multicenter study conducted by experienced rheumatologists
por: Zhang, Hua, et al.
Publicado: (2023)

Effect of Inhibition of the JAK2/STAT3 Signaling Pathway on the Th17/IL-17 Axis in Acute Cellular Rejection After Heart Transplantation in Mice
por: Zhang, Ming, et al.
Publicado: (2021)

Production of IL-17: What’s STAT got to do with it?
por: McGovern, Jenny L., et al.
Publicado: (2012)

Differentiation of IL-26(+) T(H)17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
por: Fries, Anissa, et al.
Publicado: (2023)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

IL-17C/IL-17RE: Emergence of a Unique Axis in T(H)17 Biology
por: Nies, Jasper F., et al.
Publicado: (2020)

Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis
por: QIN, SI, et al.
Publicado: (2014)

The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
por: Liu, Ningyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n0m57mpdmeu1v4556dq1pd4c0d